A carregar...
Beyond Telaprevir and Boceprevir: Resistance and New Agents for Hepatitis C Virus Infection
The addition of the hepatitis C virus (HCV) protease inhibitors telaprevir and boceprevir to peginterferon alfa with ribavirin therapy has increased cure rates in HCV infection. Numerous other direct-acting antivirals (DAAs) are in advanced stages of development, including next-generation protease i...
Na minha lista:
| Publicado no: | Top Antivir Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IAS-USA
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148907/ https://ncbi.nlm.nih.gov/pubmed/23154254 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|